Skip to main content

Table 2 Culture source, clinical diagnosis, and outcome among carbapenem-resistant Enterobacter cloacae complex cases

From: Molecular epidemiological analysis and risk factors for acquisition of carbapenemase-producing Enterobacter cloacae complex in a Japanese university hospital

 CREC (n = 39)OR (95% CI)p
CPEC (n = 20)Non-CPEC (n = 19)
Culture source
 Sterile site23  
  Blood120.46 (0.007–9.51)0.605
  Abscess10 1
  Vascular graft01 0.487
 Non-sterile site1816  
  Sputum1144.40 (0.94–25.0)0.048
  Peritoneal fluid (not punctured)240.43 (0.03–3.46)0.407
  Urine130.29 (0.05–4.02)0.342
  Bile120.46 (0.007–9.51)0.605
  Oral swab01 0.487
  Stool230.60 (0.04–5.96)0.661
Clinical diagnosis
 Colonisation1172.06 (0.49–9.17)0.341
  Pneumonia522.76 (0.38–33.1)0.407
  Peritonitis15a0.15 (0.003–1.60)0.092
  Pyelonephritis03 0.106
  Bacteremia12a0.46 (0.007–9.51)0.605
  Cholangitis10 1
  Vascular graft infection01 0.487
  Abscess10 1
 Required intensive care unit stay in the 7 days after positive culture1071.67 (0.40–7.48)0.523
 Died at the end of the 30-day evaluation120.46 (0.007–9.51)0.605
  Among sterile site positive culture01  
  Among non-sterile site positive culture11  
 Died during hospitalisation321.48 (0.15–19.9)1
  Among sterile site positive culture11  
  Among non-sterile site positive culture21  
  1. aOne case had peritonitis with bacteremia
  2. Note. OR Odds ratio, CI Confidence interval, CREC Carbapenem-resistant Enterobacter cloacae complex, CPEC Carbapenemase-producing Enterobacter cloacae complex